Evidence map›Paper›PMID 38732912›Full record

ArticleSensors (Basel, Switzerland)2024

Combining the Benefits of Biotin-Streptavidin Aptamer Immobilization with the Versatility of Ni-NTA Regeneration Strategies for SPR.

Eliza K Hanson, Rebecca J Whelan

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Construction of αJournal of separation science · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eliza K HansonDepartment of Chemistry, University of Kansas, Lawrence, KS 66045, USA.ORCID 0000-0003-1118-184X
Rebecca J WhelanDepartment of Chemistry, University of Kansas, Lawrence, KS 66045, USA.ORCID 0000-0002-9293-1528

Funding

Targeted proteomics of MUC16 to enable early detection of ovarian cancer recurrenceR21CA267532 · NCI · UNIVERSITY OF NOTRE DAME · PI WHELAN, REBECCA JEAN · 2022 to 2023
$412k
NCI NIH HHS R21 CA267532NCI NIH HHS R21CA267532
6 · The paper itself

Abstract

The high affinity of the biotin-streptavidin interaction has made this non-covalent coupling an indispensable strategy for the immobilization and enrichment of biomolecular affinity reagents. However, the irreversible nature of the biotin-streptavidin bond renders surfaces functionalized using this strategy permanently modified and not amenable to regeneration strategies that could increase assay reusability and throughput. To increase the utility of biotinylated targets, we here introduce a method for reversibly immobilizing biotinylated thrombin-binding aptamers onto a Ni-nitrilotriacetic acid (Ni-NTA) sensor chip using 6xHis-tagged streptavidin as a regenerable capture ligand. This approach enabled the reproducible immobilization of aptamers and measurements of aptamer-protein interaction in a surface plasmon resonance assay. The immobilized aptamer surface was stable during five experiments over two days, despite the reversible attachment of 6xHis-streptavidin to the Ni-NTA surface. In addition, we demonstrate the reproducibility of this immobilization method and the affinity assays performed using it. Finally, we verify the specificity of the biotin tag-streptavidin interaction and assess the efficiency of a straightforward method to regenerate and reuse the surface. The method described here will allow researchers to leverage the versatility and stability of the biotin-streptavidin interaction while increasing throughput and improving assay efficiency.

Indexed as

Aptamers, NucleotideBiotinNitrilotriacetic AcidStreptavidinSurface Plasmon ResonanceBiosensing TechniquesOrganometallic CompoundsThrombinAptamers, NucleotideBiotinnickel nitrilotriacetic acidNitrilotriacetic AcidOrganometallic CompoundsStreptavidinThrombinaptamersbiotin–streptavidin immobilizationNi2+-nitrilotriacetic acid (NTA)surface plasmon resonance (SPR)

Identifiers

PMID38732912
PMCPMC11086168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.